
A New Program Helps Adults with Type 1 Diabetes Manage Severe Lows
A clinical trial found that a psychoeducation program called HARPdoc helped address the cognitive and emotional barriers that make it harder for some adults to recognize and avoid dangerously low blood sugar episodes.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- HARPdoc is designed for people with Type 1 diabetes who experience severe hypoglycemic episodes despite receiving optimal diabetes care
- The program focuses on cognitive and motivational barriers—the mental and emotional factors that can interfere with hypoglycemia awareness and avoidance
- Adults who received HARPdoc perceived it as more appropriate for their needs than an existing program called Blood Glucose Awareness Training (BGAT)
- The program also showed potential improvements in attitudes toward awareness, diabetes distress, anxiety, and depression
- Both people with diabetes and healthcare professionals found HARPdoc acceptable and feasible to use
What Is HARPdoc?
HARPdoc stands for the Hypoglycemia Awareness Restoration Program. It's a psychoeducation program—meaning it combines education about diabetes with psychological support—designed specifically for adults with Type 1 diabetes who experience severe low blood sugar episodes that continue even with optimal diabetes management.
Unlike traditional blood sugar awareness training, HARPdoc takes a different approach. It addresses the cognitive and motivational barriers that can make hypoglycemia awareness more difficult. In other words, it targets the mental and emotional factors that may interfere with a person's ability to recognize and prevent dangerous lows.
What the Trial Found
Researchers conducted a hybrid clinical trial between July 2018 and December 2019 in the United Kingdom and United States. They compared how adults with Type 1 diabetes, healthcare professionals, and family members perceived HARPdoc compared to an existing program called Blood Glucose Awareness Training (BGAT).
At 12 months, people who received HARPdoc felt the program was more appropriate for their situation than BGAT. The researchers also looked at whether the program improved cognitive and mental health outcomes, including attitudes toward awareness, diabetes distress, anxiety, and depression.
Who Participated and Why It Matters
The trial included adults with Type 1 diabetes who had problematic hypoglycemia—meaning they were experiencing severe low blood sugar episodes despite receiving the best available diabetes care. This is a specific and challenging situation that standard diabetes management doesn't always address.
By surveying not only people with diabetes but also healthcare professionals and family members, researchers could understand how different perspectives viewed the program's acceptability, feasibility, and appropriateness. This broader feedback helps determine whether a program might work in real-world clinical settings.
What This Means for People Living with Type 1 Diabetes
For adults struggling with severe lows despite good diabetes management, HARPdoc offers a new option that specifically addresses the mental and emotional barriers—not just the technical skills—related to hypoglycemia awareness. The trial suggests that this targeted approach may be perceived as more relevant and useful than existing programs.
If you or a loved one experiences severe hypoglycemia that continues despite optimal care, it's worth discussing HARPdoc with your healthcare team to see whether this type of program might be available or appropriate for your situation.
Evidence label
Source: Frontiers in health services. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature
- Living With T1DHow Thoughts About Thoughts May Fuel Emotional Stress in Type 1 DiabetesPubMed indexed literature
- Living With T1DDigital Health Literacy May Help Teens with Type 1 Diabetes Improve Self-Care and Well-BeingPubMed indexed literature